GSK Global Twitter

  • Simon Dingemans, CFO: “We’re targeting additional cost savings of £1bn/yr by 2020 to fund new launches, R&D and mit……

    26.7.2017 14:11:09

  • Simon Dingemans, CFO: “Over the last several quarters we have stepped up pharma R&D spending as we advance our pipeline” $GSK

    26.7.2017 13:53:12

  • Emma Walmsley, CEO: "Another priority is company-wide focus on Performance which must be sustainable, ethical and m……

    26.7.2017 13:35:14

Seuraa meitä Twitterissä